Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen B...
Singapore: Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has provided Ast...
Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from San...
Singapore: Israel-based Teva Pharmaceutical and Canada-based Xenon Pharmaceuticals have entered into a collaborative dev...
Singapore: Ironwood Pharmaceuticals and AstraZeneca Pharmaceuticals have announced the initiation of a phase III clinica...
Singapore: NanoMaterials Technology (NMT), a Singapore based company, has signed an exclusive material supply agreement ...
A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundatio...
Singapore: Specialised Therapeutics Australia (STA) is going to publish abstracts related to its phase III metastatic me...
Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint d...
Singapore: Roche has launched FLOW system, a user defined system for workflow chain from primary sample handling to qPCR...
Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...
Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan'...
Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Dev...
Singapore: GlaxoSmithKline has recieved European Commission (EC) marketing authorisation for Mekinist (trametinib) as a ...
Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed...
Singapore: Merck Millipore is boosting its portfolio for drug bioavailability, including products for all types of dosag...
Singapore: Singapore has announced 8 biomedical sciences research programmes to advance understanding and treatment of d...
Singapore: Boehringer Ingelheim, one of the world's leading pharmaceutical companies, will acquire the global rights of ...
